Target intelligence / Profile preview

Sulfonylurea receptor 1-Transient receptor potential melastatin 4 ion channel complex (SUR1-TRPM4)

Target
SUR1-TRPM4
Molecular classification
Ion channel, Heteromeric protein complex, ABC transporter family, Transient receptor potential channel
01

Overview

The Sulfonylurea receptor 1-Transient receptor potential melastatin 4 (SUR1-TRPM4) ion channel complex is a heteromeric structure that plays a pivotal role in the development of cerebral edema following acute central nervous system (CNS) injury. This complex is unique because it is not constitutively expressed in healthy CNS tissues but is de novo upregulated in neurons, astrocytes, and capillary endothelial cells following insults such as ischemic stroke, traumatic brain injury, or subarachnoid hemorrhage (Simard et al., 2006, Nature Medicine; Woo et al., 2013, J Cereb Blood Flow Metab). The channel is composed of the regulatory subunit SUR1 (encoded by ABCC8) and the pore-forming subunit TRPM4; it is activated by a decrease in intracellular ATP and an increase in intracellular calcium (Simard et al., 2007, Biochim Biophys Acta). Once open, the channel allows a non-selective influx of monovalent cations, which leads to water influx, oncotic cell swelling, and eventually, the breakdown of the blood-brain barrier and catastrophic tissue damage (Kurland et al., 2013, Transl Stroke Res). Because of its specific expression in injured tissue, it has become a high-interest therapeutic target. The sulfonylurea drug glibenclamide (glyburide) acts as a potent inhibitor of this complex, and clinical trials have investigated its efficacy in reducing brain swelling and improving survival in patients with large territory strokes (Sheth et al., 2016, Lancet Neurol).

Other names
SUR1-TRPM4 channelNCCa-ATP channelNon-selective cation channel activated by calcium and inhibited by ATPABCC8-TRPM4 complex
02

Mechanism of action

Inhibition of the SUR1 regulatory subunit to prevent the opening of the TRPM4 pore, thereby blocking the influx of monovalent cations and preventing oncotic cell swelling.

03

Biological functions

Ion transportMembrane potential regulationCell volume regulationCytotoxic edema mediation
04

Disease associations

Ischemic strokeTraumatic brain injurySpinal cord injurySubarachnoid hemorrhageCerebral edema
05

Safety considerations

HypoglycemiaOff-target inhibition of pancreatic SUR1
06

Interacting drugs

Glibenclamide

2 more in the full profile.

07

Biomarkers

SUR1 expression in vascular endotheliumCerebral edema volume (imaging)

Beyond the preview

Go deeper on Sulfonylurea receptor 1-Transient receptor potential melastatin 4 ion channel complex (SUR1-TRPM4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sulfonylurea receptor 1-Transient receptor potential melastatin 4 ion channel complex (SUR1-TRPM4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call